Haemonetics HAE Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's accrued manufacturing costs?
- Haemonetics (HAE) reported accrued manufacturing costs of $68.19M in Q1 2026.
- How has Haemonetics's accrued manufacturing costs changed year-over-year?
- Haemonetics's accrued manufacturing costs increased by 14.8% year-over-year, from $59.42M to $68.19M.
- What is the long-term trend for Haemonetics's accrued manufacturing costs?
- Over 5 years (2021 to 2026), Haemonetics's accrued manufacturing costs has grown at a 7.5% compound annual growth rate (CAGR), from $47.6M to $68.19M.